Home/ Supplements/ Saw Palmetto/ Clinical Prostate Suppport

Clinical Prostate Suppport

product on market Capsule Natural Clinician Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 54% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

✨ AI-generated · Qwen 3.6 · methodology

This formula utilizes saw palmetto, nettle, and pygeum africanum, which have moderate evidence for managing urinary symptoms associated with enlarged prostates. Beta-sitosterol and pumpkin seed extract are also included to support lower urinary tract function. Research indicates these botanical ingredients are generally well-tolerated and safe for most users.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Clinical Prostate Suppport
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
54%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

320 mg
Market median: 320.0mg (426 products) 26 studies (A:0, B:5)
Nettle
200 mg
Pygeum africanum
100 mg
Pumpkin
100 mg
Beta Sitosterol Complex
100 mg
10 mg
Market median: 250.0mg (337 products) 127 studies (A:1, B:41)
2 mg
Market median: 10.0mg (35 products) 6 studies (A:0, B:2)
L-Alanine
50 mg
L-Glycine
50 mg
L-Glutamic Acid
50 mg
Isoflavones
20 mg
30 IU (100% DV)
1.3× RDA — within safe limits 179 studies (A:3, B:90)
30 mg (200% DV)
2.7× RDA — within safe limits 263 studies (A:6, B:134)
Vitamin A
1000 IU (20% DV)
Vitamin C
12 mg (20% DV)
80 IU (20% DV)
Within RDA (0.1× RDA) 608 studies (A:16, B:251)
6 mcg (7% DV)
Within RDA (0.1× RDA) 275 studies (A:9, B:175)
0.3 mg (20% DV)
Within RDA (0.2× RDA) 76 studies (A:0, B:33)
0.34 mg (20% DV)
Within RDA (0.3× RDA) 13 studies (A:0, B:1)
4 mg (20% DV)
Within RDA (0.3× RDA) 196 studies (A:5, B:63)
0.4 mg (20% DV)
Within RDA (0.3× RDA) 114 studies (A:3, B:35)
80 mcg (20% DV)
Within RDA (0.2× RDA) 226 studies (A:10, B:105)
2 mcg (33% DV)
Within RDA (0.8× RDA) 139 studies (A:1, B:44)
6 mcg (2% DV)
Within RDA (0.2× RDA) 27 studies (A:0, B:11)
2 mg (20% DV)
Within RDA (0.4× RDA) 2 studies — no high-quality reviews
Calcium
32.4 mg (3% DV)
Iron
3.6 mg (20% DV)
20 mg (5% DV)
Market median: 500.0mg (1 products) 316 studies (A:8, B:159)
Potassium
16 mg (1% DV)
30 mcg (20% DV)
Within RDA (0.2× RDA) 245 studies (A:4, B:133)
400 mcg (20% DV)
Within RDA (0.4× RDA) 37 studies (A:0, B:11)
400 mcg (20% DV)
Within RDA (0.2× RDA) 9 studies — no high-quality reviews
30 mcg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
4 mcg (6% DV)
Within RDA (0.1× RDA) 173 studies (A:0, B:67)
24 mcg (20% DV)
Within RDA (0.7× RDA) 199 studies (A:1, B:55)
15 mcg
Within RDA (0.3× RDA) 3 studies — no high-quality reviews
2 mcg
Market median: 0.5mg (6 products) 1 studies (A:0, B:1)

Other Ingredients

All Natural Vegetable Source of
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Take two capsules daily with 8 oz. of pure water.

Additional Information

PATENT PENDING CLINICAL GRADE FORMULATION

Metadata

Product Details

UPC / SKU0 36733 00802 0
DSLD Entry Date2013-02-25
Product TypeOther Combinations
FormCapsule
BrandNatural Clinician
DSLD ID18677
Data Updated2026-04-11
Research

Research Evidence

35
Research Sources
52
Avg Quality
15
Meta Analysis
11
Systematic Review
7
Rct
1
Narrative Review
1
Openfda Safety
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2009 PubMed DOI
B Serenoa repens for benign prostatic hyperplasia
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
B Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement: A systematic review and meta-analysis
Meta Analysis Investigative and clinical urology 2021 PubMed DOI
B Clinical Efficacy of Serenoa repens Versus Placebo Versus Alpha-blockers for the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Enlargement: A Systematic Review and Network Meta-analysis of Randomized Placebo-controlled Clinical Trials
Systematic Review European urology focus 2021 PubMed DOI
B Non-hormonal treatment for male infertility: the potential role of Serenoa repens, selenium and lycopene
Systematic Review European review for medical and pharmacological sciences 2019 PubMed DOI
B Comparison of Serenoa repens With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis
Meta Analysis American journal of men's health 2020 PubMed DOI
B Serenoa repens monotherapy for benign prostatic hyperplasia (BPH): an updated Cochrane systematic review
Systematic Review BJU international 2012 PubMed DOI
B Effects of dietary supplements on androgenetic alopecia: a systematic review and network meta-analysis
Systematic Review Frontiers in nutrition 2025 PubMed DOI
C Benign prostate hyperplasia and nutrition
Systematic Review Clinical nutrition ESPEN 2019 PubMed DOI
C American palm ethnomedicine: a meta-analysis
Meta Analysis Journal of ethnobiology and ethnomedicine 2009 PubMed DOI
View all evidence for Saw Palmetto →
Compare

Similar Products

Pro-Male
Douglas Laboratories · Capsule
100
Pro-Male Forte
Douglas Laboratories · Capsule
100
Pro-Male Forte
Douglas Laboratories · Capsule
100
Saw Palmetto Formula
GNC Mega Men · Capsule
100
Saw Palmetto
GNC Herbal Plus Standardized · Capsule
100
View all Saw Palmetto products →
Saw Palmetto research Best Saw Palmetto All Saw Palmetto products More from Natural Clinician View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.